NCT00701831View on ClinicalTrials.gov

Assessment of Insulin Glargine in Type 2 Patients for Good Glycemic Control

PHASE4CompletedINTERVENTIONAL

Enrollment

241

Participants

Timeline

Start Date

May 31, 2008

Primary Completion Date

October 31, 2010

Study Completion Date

October 31, 2010

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG

Insulin glargine

The dose is titrated according to patient needs

Trial Locations (1)

Unknown

Sanofi-Aventis Administrative Office, Istanbul

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY